Related Experiment Video
Updated: Jun 19, 2025

07:47
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
Published on: December 15, 2023
662
Non-Invasive 3D Breast Tumor Localization: A Viable Alternative to Invasive Tumor Marking
Dragana Bjelica1, Natasa Colakovic2,3, Svetlana Opric4,5
1Department of Radiology, University Hospital Medical Center "Bežanijska kosa", Zorza Matea bb, 11070 Belgrade, Serbia.
Cancers
|July 27, 2024
Summary
A new non-invasive technique accurately locates breast tumors after neoadjuvant systemic therapy (NAST), offering a safe alternative to invasive marking for precise surgical removal of regressed tumors.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Imaging
Background:
- Neoadjuvant systemic therapy (NAST) can lead to complete tumor regression in breast cancer.
- Standard invasive tumor marking before NAST can be challenging after tumor regression.
- A novel non-invasive 3D tumor localization technique is proposed as an alternative.
Purpose of the Study:
- To describe and evaluate a novel non-invasive 3D breast tumor localization technique.
- To assess the feasibility and accuracy of this technique for guiding surgery after NAST.
- To provide an alternative to invasive marking for complete tumor bed excision.
Main Methods:
- Prospective, single-arm study evaluating a non-invasive 3D tumor localization technique.
- Feasibility and precision assessed via histological analysis of excised tissue.
- Patient selection based on tumor ultrasound visibility and response to NAST.
Main Results:
- The technique was applied to 31/79 patients (39%) with complete clinical regression after NAST.
- Histological analysis confirmed 100% precision in locating tumor beds.
- No positive margins were observed in cases with microscopic cancer residues (7/31).
Conclusions:
- The non-invasive 3D localization technique is feasible and accurate for guiding surgery post-NAST.
- It offers a viable alternative to invasive marking, particularly in centers with limited resources.
- Inadequate tumor ultrasound visibility remains a limitation.

